LI Zi-ming. Clinical Efficacy, Immune Response, and Safety of NK Cell Therapy in Advanced Non-Small Cell Lung Cancer: A Preliminary Study[J]. Journal of Evidence-Based Medicine, 2025, 25(1): 24-24, 26. DOI: 10.12019/j.issn.1671-5144.202502012
|
Citation:
|
LI Zi-ming. Clinical Efficacy, Immune Response, and Safety of NK Cell Therapy in Advanced Non-Small Cell Lung Cancer: A Preliminary Study[J]. Journal of Evidence-Based Medicine, 2025, 25(1): 24-24, 26. DOI: 10.12019/j.issn.1671-5144.202502012
|
LI Zi-ming. Clinical Efficacy, Immune Response, and Safety of NK Cell Therapy in Advanced Non-Small Cell Lung Cancer: A Preliminary Study[J]. Journal of Evidence-Based Medicine, 2025, 25(1): 24-24, 26. DOI: 10.12019/j.issn.1671-5144.202502012
|
Citation:
|
LI Zi-ming. Clinical Efficacy, Immune Response, and Safety of NK Cell Therapy in Advanced Non-Small Cell Lung Cancer: A Preliminary Study[J]. Journal of Evidence-Based Medicine, 2025, 25(1): 24-24, 26. DOI: 10.12019/j.issn.1671-5144.202502012
|
DownLoad: